PECAM1 and medullary thyroid gland carcinoma: The rich vascularization in the control MTC group, evidenced by the CD31 staining, was significantly reduced in specimens explanted from the drug-treated mice (Fig. 5), indicating a marked antiangiogenic effect exerted by AF3485.